NCR3 and acute myeloid leukemia: In addition, AML cells which present ligands for NK activating receptors, namely CD112 and CD155, can decrease the expression of some other NK cell activating receptors, namely DNAM-1, NKp30, and NKp46, by physically interacting with NK cells [59,60].